Adrian Gottschalk

2021

In 2021, Adrian Gottschalk earned a total compensation of $4.3M as President and Chief Executive Officer at Foghorn Therapeutics, a 64% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$405,000
Option Awards$3,370,482
Salary$540,000
Total$4,315,482

Gottschalk received $3.4M in option awards, accounting for 78% of the total pay in 2021.

Gottschalk also received $405K in non-equity incentive plan and $540K in salary.

Rankings

In 2021, Adrian Gottschalk's compensation ranked 3,075th out of 12,415 executives tracked by ExecPay. In other words, Gottschalk earned more than 75.2% of executives.

ClassificationRankingPercentile
All
3,075
out of 12,415
75th
Division
Manufacturing
1,231
out of 5,505
78th
Major group
Chemicals And Allied Products
494
out of 2,375
79th
Industry group
Drugs
436
out of 2,096
79th
Industry
Pharmaceutical Preparations
297
out of 1,546
81st
Source: SEC filing on April 29, 2022.

Gottschalk's colleagues

We found three more compensation records of executives who worked with Adrian Gottschalk at Foghorn Therapeutics in 2021.

2021

Allan Reine

Foghorn Therapeutics

Chief Financial Officer

2021

Carl Decicco

Foghorn Therapeutics

Chief Scientific Officer

2021

Samuel Agresta

Foghorn Therapeutics

Chief Medical Officer

News

In-depth

You may also like